![Mikkel Noerholm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mikkel Noerholm
Corporate Officer/Principal chez Exosome Diagnostics, Inc.
Profil
Mikkel Noerholm is currently working as Vice President-Product Development at Exosome Diagnostics, Inc. He holds an MBA from Babson College and a doctorate from the Technical University of Denmark.
Postes actifs de Mikkel Noerholm
Sociétés | Poste | Début |
---|---|---|
Exosome Diagnostics, Inc.
![]() Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formation de Mikkel Noerholm
Technical University of Denmark | Doctorate Degree |
Babson College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Exosome Diagnostics, Inc.
![]() Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |